Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 3 1

Status

Completed 7Unknown 4Terminated 4Recruiting 3Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 4NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Breast Neoplasms 1477Neoplasms 999Colorectal Neoplasms 832Carcinoma, Non-Small-Cell Lung 724Carcinoma, Hepatocellular 683Stomach Neoplasms 648Lung Neoplasms 584Prostatic Neoplasms 543Pancreatic Neoplasms 456Rectal Neoplasms 339Uterine Cervical Neoplasms 303Colonic Neoplasms 295Neoplasm Metastasis 294Ovarian Neoplasms 285Esophageal Neoplasms 279Recurrence 278Leukemia, Myeloid, Acute 253Head and Neck Neoplasms 241Multiple Myeloma 232Brain Neoplasms 204Polycystic Ovary Syndrome 200Nasopharyngeal Carcinoma 198Melanoma 198Precursor Cell Lymphoblastic Leukemia-Lymphoma 195Urinary Bladder Neoplasms 193Lymphoma 178Liver Neoplasms 178Endometrial Neoplasms 159Motor Activity 147Lymphoma, Large B-Cell, Diffuse 141

Interventions

Celecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × OTHER × Hand-Foot Syndrome × Clear all
NCT06583369 2024-09-04

The Efficacy and Safety of Liangxue Ointment in the Treatment of Hand-foot Syndrome Caused by VEGFR-TKI Drugs

Peking University Cancer Hospital & Institute

Phase NA Unknown
220 enrolled
DermatologicGenitourinary

Carcinoma, Renal Cell, Melanoma, Hand-Foot Syndrome

NCT06441513 2024-06-04

The Preventive Effect of Chemotherapy-induced Hand-foot Syndrome

Peking University Third Hospital

Phase NA Unknown
130 enrolled

Neoplasms, Hand-Foot Syndrome

NCT05327751 2022-04-14

HFS

Tanta University

Phase 3 Unknown
44 enrolled
Gastrointestinal

Colorectal Neoplasms, Hand-Foot Syndrome

NCT01291628 2012-01-19

Prevention of Capecitabine Induced Hand and Foot Syndrome

Rabin Medical Center

Phase NA Unknown
10 enrolled

Neoplasms, Hand-Foot Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡